$ELVN

$42.39▲ -6.8% YTD

7 SEC 13D/G filings tracked · Last updated Oct 6, 2026

Filing History

ELVN ▼ -6.8% - Enliven Therapeutics, Inc.

CP $42.39▲ -6.8%Oct 6, 2026 · ThinkSabio Blog

$ELVN ELVN - Enliven Therapeutics Announces FDA Alignment on ENABLE-2 Phase 3 Trial Design for Relcobatinib (ELVN-001) in Previously Treated Chronic M…

News

ELVN ▲ +0.9% - Enliven Therapeutics, Inc.

CP $46.67▲ +0.9%Oct 2, 2026 · ThinkSabio Blog

$ELVN int Overweight @ MS pt 70…

News

ELVN ▲ +1.1% - Enliven Therapeutics, Inc.

CP $59.65▲ +1.1%Sep 3, 2026 · ThinkSabio Blog

$ELVN ELVN - Enliven Therapeutics to Present at Upcoming Investor Conferences…

News

ELVN ▲ +0.1% - Enliven Therapeutics, Inc.

CP $57.89▲ +0.1%Aug 31, 2026 · ThinkSabio Blog

$ELVN ELVN ELVN - Enliven Therapeutics Announces Oral and Poster Presentations at the Society of Hematologic Oncology (SOHO) 2026 Annual Meeting…

SEC 13D/G

ELVN - Enliven Therapeutics, Inc. - SEC Filing Update (06-AUG-2026) | ThinkSabio - Stocks Simplified

$61.28▲ 293.83%Aug 6, 2026 · ThinkSabio Blog

$ELVN SEC 13D/G institutional ownership filing. Healthcare sector. SEC Filing Update: #ELVN Enliven Therapeutics, Inc. : $61.28 Sector: Healthcare | Y…

SEC 13D/G

$ELVN SEC Filing Update (24-JUN-2026) | ThinkSabio - Stocks Simplified

$47.60▲ 205.91%Jun 24, 2026 · ThinkSabio Blog

SEC Filing Update: #ELVN : $47.60 Sector: Healthcare | YTD: 🔼+ 205.91% The SEC disclosed Today (24-JUN-2026) that ORBIMED ADVISORS LLC has DECREASED #…

SEC 13D/G

$ELVN SEC Filing Update (17-JUN-2026) | ThinkSabio - Stocks Simplified

$45.00▲ 189.20%Jun 17, 2026 · ThinkSabio Blog

SEC Filing Update: #ELVN : $45.00 Sector: Healthcare | YTD: 🔼+ 189.20% The SEC disclosed Today (17-JUN-2026) that ORBIMED ADVISORS LLC has DECREASED #…